The Treatment of PD-1 Antibody Combined With Peg-IFN α in NAs-suppressed CHB Patients

Conditions: Chronic Hepatitis B Interventions: Drug: Sintilimab; Drug: Peg-IFN α-2b; Drug: NAs Sponsors: Beijing 302 Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials